We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+5.71%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.44B
AUM Growth
+$635M
Cap. Flow
+$85.7M
Cap. Flow %
1.58%
Top 10 Hldgs %
15.63%
Holding
579
New
166
Increased
105
Reduced
70
Closed
180
Avg Time Held Equity + Options
0.9 quarters
Top 10 Avg Time Held Equity + Options
0.9 quarters
Top 20 Avg Time Held Equity + Options
0.8 quarters
Avg Time Held Equity only
1 quarter
Top 10 Avg Time Held Equity only
0.9 quarters
Top 20 Avg Time Held Equity only
0.8 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 23.22%
2 Real Estate 17.69%
3 Consumer Staples 12.49%
4 Industrials 7.66%
5 Financials 7.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AVNT icon
276
Avient
AVNT
$3.47B
$548K 0.01%
+15,498
New +$493K
2013 Q4
0 quarters
NVDQ icon
277
DELISTED
Novadaq Technologies Inc.
NVDQ
$527K 0.01%
+31,967
New +$530K
2013 Q4
0 quarters
TMUS icon
278
CALL
T-Mobile US
TMUS
$159B
$464K 0.01%
+70,000
New +$1.92M
2013 Q4
0 quarters
NSPH
279
DELISTED
NANOSPHERE INC. COM NEW
NSPH
$458K 0.01%
10,000
-3,750
-27% -$157K
2013 Q3
1 quarter
ETFC
280
CALL
DELISTED
E*Trade Financial Corporation
ETFC
$456K 0.01%
125,000
-345,000
-73% -$6.13M
2013 Q2
2 quarters
FCX icon
281
CALL
Freeport-McMoran
FCX
$106B
$446K 0.01%
+400,000
New +$14.2M
2013 Q4
0 quarters
KOF icon
282
Coca-Cola Femsa
KOF
$23.1B
$427K 0.01%
+3,505
New +$421K
2013 Q4
0 quarters
GCVRZ
283
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$409K 0.01%
1,203,178
– –
2013 Q2
2 quarters
WELL.PRI icon
284
DELISTED
Welltower Inc.
WELL.PRI
$387K 0.01%
7,500
– –
2013 Q3
1 quarter
IBTX icon
285
DELISTED
Independent Bank Group, Inc.
IBTX
$380K 0.01%
+7,662
New +$317K
2013 Q4
0 quarters
HLF icon
286
CALL
Herbalife
HLF
$1.37B
$379K 0.01%
+400,000
New +$13.9M
2013 Q4
0 quarters
CLX icon
287
PUT
Clorox
CLX
$10.1B
$355K 0.01%
+400,000
New +$36M
2013 Q4
0 quarters
EA icon
288
DELISTED
Electronic Arts
EA
$325K 0.01%
+14,157
New +$340K
2013 Q4
0 quarters
MYE icon
289
Myers Industries
MYE
$1.15B
$317K 0.01%
+15,000
New +$292K
2013 Q4
0 quarters
NAV
290
PUT
DELISTED
Navistar International
NAV
$302K 0.01%
+100,000
New +$3.82M
2013 Q4
0 quarters
CCK icon
291
Crown Holdings
CCK
$11.8B
$284K 0.01%
+6,378
New +$273K
2013 Q4
0 quarters
GM icon
292
General Motors
GM
$72.6B
$275K 0.01%
+6,732
New +$254K
2013 Q4
0 quarters
CPA icon
293
Copa Holdings
CPA
$5.48B
$274K 0.01%
+1,710
New +$258K
2013 Q4
0 quarters
CPB icon
294
CALL
Campbell Soup
CPB
$5.73B
$270K 0.01%
+300,000
New +$12.4M
2013 Q4
0 quarters
BAP icon
295
Credicorp
BAP
$30.3B
$261K ﹤0.01%
+2,044
New +$260K
2013 Q4
0 quarters
RGLS icon
296
DELISTED
Regulus Therapeutics
RGLS
$180K ﹤0.01%
203
+9
+5% +$7.75K
2013 Q3
1 quarter
EBAY icon
297
CALL
eBay
EBAY
$49.9B
$175K ﹤0.01%
+83,160
New +$1.84M
2013 Q4
0 quarters
MERU
298
DELISTED
MERU NETWORKS INC COM STK (DE)
MERU
$172K ﹤0.01%
40,000
-40,000
-50% -$139K
2013 Q2
2 quarters
BPZ
299
DELISTED
BPZ RESOURCES INC COM STK
BPZ
$171K ﹤0.01%
+94,050
New +$189K
2013 Q4
0 quarters
KMB icon
300
PUT
Kimberly-Clark
KMB
$32.5B
$160K ﹤0.01%
+104,300
New +$10.4M
2013 Q4
0 quarters

Similar funds

UBS O'Connor's Q4 2013 Portfolio in Review

As of Q4 2013, UBS O'Connor held 579 positions worth $5.44B, up 13% from $4.81B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS O'Connor's Q4 2013 filing shows 166 new, 105 increased, 70 reduced and 180 closed positions. Its largest new stake was American Airlines Group: 2,596,600 shares worth $65.6M. The largest sale was ONYX PHARMACEUTICALS INC, an estimated $60.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 30% a quarter earlier, followed by Real Estate and Consumer Staples.

  • UBS O'Connor's largest Q4 2013 buy was American Airlines Group: 2,596,600 shares worth $65.6M.
  • UBS O'Connor added most to Crown Castle in Q4 2013, an estimated $53.8M increase.
  • UBS O'Connor's biggest Q4 2013 reduction was Colgate-Palmolive, cutting an estimated $46.1M.
  • UBS O'Connor fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $60.5M.
  • UBS O'Connor's ten largest holdings make up 16% of its $5.44B portfolio in Q4 2013.
  • UBS O'Connor opened 166 new positions and closed 180 in Q4 2013.
  • UBS O'Connor's portfolio value rose 13% quarter-over-quarter to $5.44B.

Based on UBS O'Connor's 13F filing for Q4 2013, filed 13 Feb 2014.